Updates in Psoriatic Arthritis - October 4, 2017
Join Catherine Bakewell, M.D., RhMSUS, for this one hour presentation that addresses the latest updates in Psoriatic Arthritis including biologic treatment, burden of disease, comorbidities and much more.
To register for this course, please login and select the Take Course button at right.
- Provided by the National Psoriasis Foundation
- Supported by educational grants from Novartis Pharmaceuticals Corporation, Celgene Corporation, Valeant Pharmaceuticals, Mallinckrodt Pharmaceuticals, Pfizer Inc., and Bristol Myers Squibb.
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Psoriasis Foundation designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Dermatologists, rheumatologists, primary care physicians, and allied health providers
- Recognize the important clinical features and manifestations that may support the diagnosis and assessment of psoriatic arthritis (PsA).
- Describe the beneficial aspects of optimizing interdisciplinary exchanges in the care of the patient with PsA and related comorbidities.
Questions? Contact us at firstname.lastname@example.org
Catherine Bakewell, M.D., RhMSUS
Intermountain Healthcare Salt Lake Clinic
Salt Lake City, Utah
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing education (ACCME) to provide continuing medical education for physicicans.